It is to be noted that these trials have quite significant heterogeneity.[ 5 ] Nevertheless, patients with myocarditis and reduced LVEF should be treated with optimal medical care, according to guidelines for the management of heart failure once their hemodynamics allow the introduction of heart failure therapies.[ 6 ] CONCLUSION Treatment of fulminant myocarditis with high-dose pulse corticosteroids is evolving.
← all excerpts
Dramatic Improvement of Acute Fulminant Lymphocytic Myocarditis with Short-course Intravenous Pulse Corticosteroids: A Case Study.
1
—
—